Heron Therapeutics, Inc. (FRA:AXD2)
Germany flag Germany · Delayed Price · Currency is EUR
1.105
+0.041 (3.85%)
Last updated: Dec 5, 2025, 8:02 AM CET

Heron Therapeutics Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
2062252312788181,572
Upgrade
Market Cap Growth
22.64%-2.62%-17.01%-66.02%-47.94%-16.64%
Upgrade
Enterprise Value
2863283243127851,381
Upgrade
Last Close Price
1.101.461.552.288.2216.77
Upgrade
PS Ratio
1.561.612.012.7610.7821.69
Upgrade
PB Ratio
16.28-6.91-7.5121.9012.008.13
Upgrade
P/TBV Ratio
34.50--21.9012.008.13
Upgrade
EV/Sales Ratio
2.152.362.823.1010.3419.06
Upgrade
Debt / Equity Ratio
9.44-5.28-5.2911.602.060.10
Upgrade
Asset Turnover
0.660.630.540.390.260.21
Upgrade
Inventory Turnover
0.901.162.072.593.896.27
Upgrade
Quick Ratio
1.521.511.761.662.722.44
Upgrade
Current Ratio
2.562.292.372.503.583.07
Upgrade
Return on Equity (ROE)
----399.43%-140.53%-70.99%
Upgrade
Return on Assets (ROA)
0.43%-3.16%-24.56%-38.01%-41.04%-32.11%
Upgrade
Return on Capital (ROIC)
0.68%-4.97%-36.71%-51.84%-54.31%-40.63%
Upgrade
Return on Capital Employed (ROCE)
1.00%-8.10%-65.10%-100.40%-92.20%-88.70%
Upgrade
Earnings Yield
-5.60%-5.84%-43.34%-61.24%-23.71%-11.82%
Upgrade
FCF Yield
-12.85%-10.41%-23.65%-50.04%-22.18%-9.97%
Upgrade
Buyback Yield / Dilution
-3.91%-10.36%-26.87%-10.57%-8.48%-11.00%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.